Sign in
Join
Help
VetSurgeon.
org
Home
Veterinary Jobs
Veterinary Jobs
View all Jobs
Advertise a Vet Job
Why advertise on VetSurgeon?
Manage your Adverts
Your Invoices
Find a Locum Vet
Community
Community
Ask The Community
Ask the Community: Clinical
Ask The Community: Non-Clinical
Locums Group
SAMSoc Forum
Find Colleagues
News
News
Latest Headlines
Film Club
Film Club
All films
Veterinary Costs
Talking Points
Product Briefings
Cardiology
Dentistry
Dermatology
Diagnostic Imaging
Equine
Exotics
Farm Animal
Neurology
Ophthalmology
Orthopaedics
Pathology/Cytology
Soft Tissue Surgery
Menu
Farm Animal Veterinary News
Quick Links
News Home
Equine
RCVS & DC
Referral Practice News
Quick Links
Email Address
OK
Subscribe via RSS
Sort by:
Most Recent
|
Most Views
|
Most Comments
Posted
29 Aug 2007, 0 Comment(s)
Novartis presents research for new anthelmintic class
Published By
Arlo Guthrie
VetSurgeon News
https://www.vetsurgeon.org/cfs-file.ashx/__key/communityserver-components-sitefiles/graphics-logos/vetsurgeon_2D00_news.gif
At the WAAVP (World Association for the Advancement of Veterinary Parasitology) Congress last week, Novartis Animal Health presented what the company describes as promising data on potentially the first new livestock anthelmintic class in 25 years, offering renewed hope for farmers struggling with the devastating economic effects of parasitic worms in livestock.
The new class of parasiticides, known as Amino-Acetonitrile Derivatives (AADs), have a potentially novel mode of action which has shown promising results against all sheep and cattle gastro-intestinal nematodes, including those resistant to existing treatments. While further testing is required, early in vivo research suggests a kill rate of greater than 95 percent in key economically-important nematodes.
The new class has already been recognized by many experts as a potentially significant step forward, with the potential to significantly improve parasite management in livestock.
You can
click here
for a podcast of the highlights of the presentation which will remain available till 21st September 2007.
At the WAAVP (World Association for the Advancement of Veterinary Parasitology) Congress last week, Novartis Animal Health presented what the company describes as promising data on potentially the first new livestock anthelmintic class in 25 years...
Posted
28 Aug 2007, 0 Comment(s)
Antibiotic Therapy Required By 10% Of Dairy Calves
Published By
Arlo Guthrie
VetSurgeon News
https://www.vetsurgeon.org/cfs-file.ashx/__key/communityserver-components-sitefiles/graphics-logos/vetsurgeon_2D00_news.gif
A survey of more than 400 dairy farms has found that 10% of calves required antibiotic treatment for pneumonia last winter. Before accounting for the effect on in-contact calves, Pfizer veterinary manager Carolyn Hogan calculates that losses arising from this incidence are more than £700/year for the average 168-cow herd taking part. [1]
“This could increase substantially if you added the impact on in-contacts,” she says. “A major concern is that 44% of farmers said the issue of treating in-contact calves at the same time had not been discussed with their vet.”
[1] Andrews A.H (2000) Cattle Practice Vol 8 Part 2: 109-114. This paper estimates a case of pneumonia in a dairy calf to cost £43 per treated animal on average. In the survey being reported here, the average farm reported 17 cases of pneumonia in the past year requiring antibiotic treatment. Cost estimate = 17 cases x £43/case = £731.
A survey of more than 400 dairy farms has found that 10% of calves required antibiotic treatment for pneumonia last winter. Before accounting for the effect on in-contact calves, Pfizer veterinary manager Carolyn Hogan calculates that losses arising...
<
Claim CPD
$cpdTitle
Add the time spent on this item to my VetSurgeon.org Personal Development Record
Time Spent (minutes)
What I learned?
How will I put what I learned into practice?
Submit